REACH’s objective is the regulation of substances of very high concern. Such substances must pass a process of approval that is defined in the REACH directive. After a transitional period, such substance may only be used after approval. The so-called "candidate list" states the substances that require approval. This list was first published on October 28, 2008 on the ECHA website and since then has been continuously updated. With the coming into effect of REACH, we are also obliged to communicate the information if a product contains a substance from the so-called "candidate list" in a concentration of more than 0.1% by mass.
Protection and well-being of patients are MedTec’s top priority. At present and in the future, our MBST magnetic resonance therapy devices do not contain any substance that is listed on the candidate list.